Back to Markets
KRKeros Therapeutics Inc

Keros Therapeutics Inc

KROSNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$11.25

-0.140000 (-1.23%)

As of 05/29/26 EDT · USD

Compare
Low: $9.79Current: $11.25High: $22.55

Key Statistics

Open

$11.51

Day High

$11.56

Day Low

$11.08

Prev. Close

$11.39

VolumeShares traded today.

154.70K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$222.66M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-3.74

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$22.55

52W LowLowest price over the past 52 weeks.

$9.79

50D MAAverage closing price over the last 50 trading days.

$11.38

200D MAAverage closing price over the last 200 trading days.

$15.29

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+0.3%

1M

+1.4%

6M

-35.0%

YTD

-39.3%

1Y

-23.3%

About

Pulmonary hypertension is a condition of increased blood pressure in the arteries of the lungs. Symptoms include shortness of breath, fainting, tiredness, chest pain, swelling of the legs, and a fast heartbeat. The condition may make it difficult to exercise. Onset is typically gradual. According to the definition at the 6th World Symposium of Pulmonary Hypertension in 2018, a patient is deemed to have pulmonary hypertension if the pulmonary mean arterial pressure is greater than 20mmHg at rest, revised down from a purely arbitrary 25mmHg, and pulmonary vascular resistance (PVR) greater than 3 Wood units.

www.kerostx.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade KROS

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.